GI 1 (Vomiting) Flashcards
Acute Chemotherapy/Cytotoxic Drug Induced Vomiting
- Pharmacology
5-HT/5HT3 Receptor Signaling (0-24 hrs)
Delayed Chemotherapy/Cytotoxic Drug Induced Vomiting
- Pharmacology
SP/NK1 Receptor Signaling (>24 hrs)
Ondansetron
- Drug Class?
5-HT(3) Receptor Antagonists
Granisetron
- Drug Class?
5-HT(3) Receptor Antagonists
Alosetron
- Drug Class?
5-HT(3) Receptor Antagonists
- Ischemic Colitis
Palonosetron
- Drug Class?
5-HT(3) Receptor Antagonists
5-HT(3) Receptor
- Mechanism of Action
Ligand Gated Ion Channel
Antagonist targets CTZ and blocks 5-HT(3) receptors from sensitizing spinal sensory neurons and blocks vagal signaling of nausea
- Slows down intestinal movement and secretions
Chlorpromazine
- Drug Class?
Dopamine Receptor 2 (D2) Antagonist
- Sedation
Perphenazine
- Drug Class?
Dopamine Receptor 2 (D2) Antagonist
Prochlorperazine
- Drug Class?
Dopamine Receptor 2 (D2) Antagonist
Trifluoperazine
- Drug Class?
Dopamine Receptor 2 (D2) Antagonist
Dopamine Receptor 2 (D2)
- MOA
G-Protein Coupled Receptor (Gq)
- Causes activation of PLC leading to an increase of IP3 and DAG levels
D2 Antagonist Targets D2 Receptors in CTZ and prevents activation
Dopamine Receptor 2 (D2)
- Adverse Effects
Involuntary Movements:
- Extrapyramidal Syndrome
- Dystonia
- Tardive Dyskinesia
Hyperprolactinemia (D2 is supposed to inhibit prolactin)
- Excessive lactation
- Men lactate
Metoclopramide
- Drug Class?
Dopamine Receptor 2 (D2) Antagonist
- Acts primarily on CTZ
- Also acts on GI (Increases Motility)
- Blocks Histamine and Muscarinic Receptors too
Metoclopramide
- Adverse Effects
Involuntary Movement:
- Spasmodic Torticollis (Neck)
- Oculogyric Crises (Eye)
Hyperprolactinemia